SCHEMBL7065460

SCHEMBL7065460

CC(C)(C)NS(=O)(=O)c1ccccc1-c1ccc(NC(=O)[C@@H]2CCCN2C(=O)O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 3/20 0.53
FPR1 P21462 1/20 0.53
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
F10 P00742 1/20 0.47
KCNH2 Q12809 1/20 0.47
ALDH1A1 P00352 3/20 0.46
MAPK1 P28482 2/20 0.46
HTT P42858 1/20 0.46
GPR119 Q8TDV5 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
NPC1 O15118 1/20 0.45
LMNA P02545 2/20 0.44
PABPC1 P11940 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
EP300 Q09472 1/20 0.43
CREBBP Q92793 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7065465 1.00 FPR2 (0.53) FPR2FPR1CYP2C9CYP2C19F10
SCHEMBL27130048 0.84 LMNA (0.62) CYP2C9CYP2C19MEN1KMT2ANPC1
SCHEMBL6987515 0.82 GPR119 (0.50) FPR2FPR1CYP2C9CYP2C19F10
SCHEMBL7065090 0.81 FPR2 (0.49) FPR2FPR1F10ALDH1A1GPR119
Cyclopentane SCHEMBL7093842 0.79 FPR2 (0.52) FPR2FPR1CYP2C9CYP2C19F10
SCHEMBL7064874 0.78 FPR2 (0.48) FPR2FPR1F10GPR119LMNA
SCHEMBL7084714 0.78 F10 (0.80) FPR2FPR1CYP2C9CYP2C19F10
SCHEMBL7083057 0.78 F10 (0.80) FPR2FPR1CYP2C9CYP2C19F10
SCHEMBL3831783 0.78 NPC1 (0.64) FPR2CYP2C9CYP2C19F10KCNH2
SCHEMBL7065471 0.78 FPR2 (0.48) FPR2FPR1F10GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030176465-A1 Cyclic amino acid derivatives MERCK PATENT GMBH (DE) 2003-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176465-A1 Cyclic amino acid derivatives F5, F11, F2 FPR2 27/4885FPR1 10/4885CYP2C9 3706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.